期刊文献+

室间隔缺损患儿介入治疗前后心肌酶谱及心功能变化的意义 被引量:4

Changes of Serum Cardiac Muscle Enzymogram and Heart Function before and after Interventional Therapy in Ventricular Septal Defect Patients and Its Clinical Significance
在线阅读 下载PDF
导出
摘要 目的探讨经导管室间隔缺损(VSD)封堵术治疗前后心肌酶谱及心功能的变化。方法检测VSD患儿介入治疗前后血清肌钙蛋白(cTnI)、磷酸肌酸激酶(CK)、肌酸激酶同工酶(CK-MB)、乳酸脱氢酶(LDH)、AST水平,并通过超声心动图(UCG)测定其左室射血分数(LVEF),对治疗前后资料进行对比分析。应用SPSS10.0软件进行统计学分析。结果介入治疗后VSD患儿较治疗前血清cTnI明显升高[(0.29±0.17)μg/Lvs(0.02±0.01)μg/L,t=9.0P<0.01],LVEF有所降低[(75.4±5.1)%vs(78.3±6.2)%,t=2.14P<0.05],血清CK、CK-MB、LDH、AST水平无明显变化(t=0.15,0.46,0.89,0.45Pa>0.05)。结论经导管VSD封堵术对患儿心肌酶及心功能有一定影响。予以相应的干预治疗仍是必要的。 Objective To explore the changes of cardiac muscle enzymogram and heart function before and after transaetheter closure of Ventrieulax septal defect (VSD). Methods The serum levels of cardiac troponin (cTnI) , eareatine kinase (CK) , lactic dehydrogenase ( LDH ), aspartate aminotransferase(AST) and the left ventrieular ejection fraction(LVEF) were detected by two -dimensional eehoeardiography,and the eharige before and after intervention was analyzed. Results The serum level of eTnI in VSD patients after treatment was markedly higher than that before intervention[ (0.29 ±0.17)μg/Lvs (0.02±0.01)μg/L,t=9.0 P〈0.01],The LVEF deereasedafter intervention [(75.4±5.1)% vs (78.3±6.2)%,t=2.14 P〈0.05].The levels of CK,CK-MB,LDH,ASTeoneotrationshadnosignifieantdifferenee between the patients before and after intervention( Pa 〉 0.05 ). Conclusion Catheterization tO treat VSD may have influence on enzymogram and the heart function ,which may be related to the minor myocardial damage during the operation.
出处 《实用儿科临床杂志》 CAS CSCD 北大核心 2008年第1期48-49,共2页 Journal of Applied Clinical Pediatrics
关键词 心肌酶谱 心功能 室间隔缺损 介入治疗 enzymogram, cardiac muscle heart function ventricular septal defect intervention treatment
  • 相关文献

参考文献15

二级参考文献88

  • 1颜红兵 柯元南 等.急性心肌梗死治疗指南[M].上海:勃林格殷格翰国际贸易有限公司,1999.227-228.
  • 2Sato Y,Kita T,Takatsu Y,et al.Biochemical markers of myocyte injury in heart failure[J].Heart,2004,90(10):1110-1113.
  • 3Stanton EB,Hansen MS,Sole MJ,et al.Cardiac troponin I,a possible predictor of survival in patients with stable congestive heart failure[J].Can J Cardiol,2005,21(1):39-43.
  • 4Srivathsan K,Showalter J,Wilkens J.Cardiovascular outcome in hospitalized patients with minimal troponin I elevation and normal creatine phosphokinase[J].Int J Cardiol,2004,97(2):221-224.
  • 5Gattis WA,O' Connor CM,Hasselblad V,et al.Usefulness of an elevated troponin-I in predicting clinical events in patients admitted with acute heart failure and acute coronary syndrome (from the RITZ-4 trial)[J].Am J Cardiol,2004,93(11):1436-1437.
  • 6Jensen JK,Mickley H.Troponin elevation-differential diagnostic considerations and prognostic importance[ J].Ugeskr Laeger,2003,165(15):1541-1545.
  • 7WuAH,Fery YJ.Biochemical differences beween cTnT and their significance for diagnosis of acute coronary syndromes[ J ].Eur Heart,1998,19(Suppl):N25-29.
  • 8Nunes JP.Cardiac troponin I in systemic diseases.A possible role for myocardial strain[J].Rev Port Cardiol,2001,20(7-8):785-788.
  • 9Missov E,Calzolari C,Pau B.Circulation cardiac troponin I in severe congestive heart failure[J].Circulation,1997,96(9):2953-2958.
  • 10Horwich TB,Patel J,MacLellan WR,et al.Cardiac troponin I is associated with impaired hemodynamics,progressive left ventricular dysfunction,and increassed mortality rates in advanced heart failure[J].Circulation,2003,108(7):833-838.

共引文献588

同被引文献37

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部